| mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
-0.27 |
1e-14 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.26 |
2e-14 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
7e-13 |
| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
-0.24 |
1e-12 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-12 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
9e-12 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-10 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
4e-10 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
7e-10 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-10 |